Menon LP, Rahman W. Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma.
J Investig Med High Impact Case Rep 2021;
9:23247096211029750. [PMID:
34218714 PMCID:
PMC8261848 DOI:
10.1177/23247096211029750]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022] Open
Abstract
Dopamine agonists are generally well tolerated and represent the first-line
therapy for prolactinomas. We report a case of a 20-year-old man with a
macroprolactinoma who developed recurrent priapism with cabergoline and
bromocriptine. Transsphenoidal pituitary adenoma resection was done with
normalization of the prolactin level. Priapism is a rare side effect of dopamine
agonists that warrants discontinuation of therapy. Patients should be educated
about this potential side effect at the time of prescribing the medication.
Collapse